Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, June, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term:
2006 / 12
PHARMAC documents that matched your search:
InPHARMation: December 2006
(3 pages, 539 KB)
2006/12/18
We’re reflecting on a successful 2005/06 year and looking towards the challenges ahead. During the year we have seen New Zealanders’ access to medicines continue to improve, with 14 new medicines funded…
Media Release: PHARMAC seeking feedback on High Cost Medicines
(2 pages, 185 KB)
2006/12/18
PHARMAC is seeking public submissions on a review of how high cost medicines are assessed and funded. High Cost Medicines are generally regarded as those treatments costing more…
An Ethical Framework for PHARMAC's Subsidy Decisions on High-Cost Pharmaceuticals
(17 pages, 850 KB)
2006/12/15
In this report I describe how Pharmac might develop an ethical framework for deciding whether and to what extent to subsidise high cost pharmaceuticals in New Zealand. Although development and marketing of ever-more expensive drugs against cancer and other serious illnesses may represent an advance in patient care, the problem of affordability will continue to challenge patients and payers like Pharmac for many years to come.
Commentary on papers by Raanan Gillon & Paul Hansen on High Cost Pharmaceuticals Review
(10 pages, 44 KB)
2006/12/15
Sandra Coney 5 April 2006 Introduction This commentary is written by a non-medical person who will approach the topic from a consumer perspective. However, it is my…
Commentary on the High Cost Medicines Review
(6 pages, 31 KB)
2006/12/15
Reviewer: Matiu Dickson Date: 17 March 2006 Introduction: I have been asked to review the reports of Professor Raanan Gillon1 and Dr Paul Hansen.2 Their reports gave responses to questions put by Pharmac3…
Consultation: How Should High Cost Medicines be Funded?
(10 pages, 351 KB)
2006/12/15
How and on what basis should PHARMAC make decisions on funding “high cost” medicines? In particular, do high cost medicines require a different approach to their funding? High cost medicines are those medicines that, unless subsidised by the Government, would be unaffordable for most New Zealanders.
Consultation: How Should High Cost Medicines be Funded?
(191 pages, 5159 KB)
2006/12/15
How and on what basis should PHARMAC make decisions on funding “high cost” medicines? In particular, do high cost medicines require a different approach to their funding? High cost medicines are those medicines that, unless subsidised by the Government, would be unaffordable for most New Zealanders.
PHARMAC and the Funding of High Cost Pharmaceuticals
(18 pages, 97 KB)
2006/12/15
Raanan Gillon, Emeritus Professor of Medical Ethics, Imperial College London PHARMAC has asked for responses to the following questions: a. What are the main economic/social justice/ethical theories relevant to how decisions on…
